Literature DB >> 21367930

The effect of insulin feedback on closed loop glucose control.

Garry M Steil1, Cesar C Palerm, Natalie Kurtz, Gayane Voskanyan, Anirban Roy, Sachiko Paz, Fouad R Kandeel.   

Abstract

CONTEXT: Initial studies of closed-loop proportional integral derivative control in individuals with type 1 diabetes showed good overnight performance, but with breakfast meal being the hardest to control and requiring supplemental carbohydrate to prevent hypoglycemia.
OBJECTIVE: The aim of this study was to assess the ability of insulin feedback to improve the breakfast-meal profile. DESIGN AND
SETTING: We performed a single center study with closed-loop control over approximately 30 h at an inpatient clinical research facility. PATIENTS: Eight adult subjects with previously diagnosed type 1 diabetes participated. INTERVENTION: Subjects received closed-loop insulin delivery with supplemental carbohydrate as needed. MAIN OUTCOME MEASURES: Outcome measures were plasma insulin concentration, model-predicted plasma insulin concentration, 2-h postprandial and 3- to 4-h glucose rate-of-change following breakfast after 1 d of closed-loop control, and the need for supplemental carbohydrate in response to nadir hypoglycemia.
RESULTS: Plasma insulin levels during closed loop were well correlated with model predictions (R = 0.86). Fasting glucose after 1 d of closed loop was not different from nighttime target (118 ± 9 vs. 110 mg/dl; P = 0.38). Two-hour postbreakfast glucose was 132 ± 16 mg/dl with stable values 3-4 h after the meal (0.03792 ± 0.0884 mg/dl · min, not different from 0; P = 0.68) and at target (97 ± 6 mg/dl, not different from 90; P = 0.28). Three subjects required supplemental carbohydrates after breakfast on d 2 of closed loop. CONCLUSIONS/
INTERPRETATION: Insulin feedback can be implemented using a model estimate of concentration. Proportional integral derivative control with insulin feedback can achieve a desired breakfast response but still requires supplemental carbohydrate to be delivered in some instances. Studies assessing more optimal control configurations and safeguards need to be conducted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367930      PMCID: PMC3085208          DOI: 10.1210/jc.2010-2578

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

Review 1.  Closed-loop insulin delivery-the path to physiological glucose control.

Authors:  G M Steil; A E Panteleon; K Rebrin
Journal:  Adv Drug Deliv Rev       Date:  2004-02-10       Impact factor: 15.470

2.  Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisiting delay and sensor offset.

Authors:  Kerstin Rebrin; Norman F Sheppard; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

3.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Authors:  K Rebrin; G M Steil; S D Mittelman; R N Bergman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 4.  In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance.

Authors:  D Elahi
Journal:  Diabetes Care       Date:  1996-03       Impact factor: 19.112

5.  Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin.

Authors:  S D Mittelman; R N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-09       Impact factor: 4.310

6.  Exaggerated hyperglycemia after a pizza meal in well-controlled diabetes.

Authors:  J A Ahern; P M Gatcomb; N A Held; W A Petit; W V Tamborlane
Journal:  Diabetes Care       Date:  1993-04       Impact factor: 19.112

7.  Insulin suppresses its own secretion in vivo.

Authors:  G M Argoud; D S Schade; R P Eaton
Journal:  Diabetes       Date:  1987-08       Impact factor: 9.461

8.  A model of the kinetics of insulin in man.

Authors:  R S Sherwin; K J Kramer; J D Tobin; P A Insel; J E Liljenquist; M Berman; R Andres
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

9.  Circadian variation of insulin requirement in insulin dependent diabetes mellitus the relationship between circadian change in insulin demand and diurnal patterns of growth hormone, cortisol and glucagon during euglycemia.

Authors:  B G Trümper; K Reschke; J Molling
Journal:  Horm Metab Res       Date:  1995-03       Impact factor: 2.936

10.  Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.

Authors:  K Rebrin; G M Steil; L Getty; R N Bergman
Journal:  Diabetes       Date:  1995-09       Impact factor: 9.461

View more
  61 in total

1.  Continuous glucose monitoring considerations for the development of a closed-loop artificial pancreas system.

Authors:  D Barry Keenan; Benyamin Grosman; Harry W Clark; Anirban Roy; Stuart A Weinzimer; Rajiv V Shah; John J Mastrototaro
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

2.  The identifiable virtual patient model: comparison of simulation and clinical closed-loop study results.

Authors:  Sami S Kanderian; Stuart A Weinzimer; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

3.  Algorithms for a closed-loop artificial pancreas: the case for proportional-integral-derivative control.

Authors:  Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

4.  Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.

Authors:  Howard Zisser; Eyal Dassau; Justin J Lee; Rebecca A Harvey; Wendy Bevier; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2015-04-21

Review 5.  The artificial pancreas: is it important to understand how the β cell controls blood glucose?

Authors:  Garry M Steil; Gerold M Grodsky
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

6.  Automated Insulin Delivery Algorithms.

Authors:  Ali Cinar
Journal:  Diabetes Spectr       Date:  2019-08

7.  Preliminary evaluation of a new semi-closed-loop insulin therapy system over the prandial period in adult patients with type 1 diabetes: the WP6.0 Diabeloop study.

Authors:  Marie Aude Quemerais; Maeva Doron; Florent Dutrech; Vincent Melki; Sylvia Franc; Michel Antonakios; Guillaume Charpentier; Helene Hanaire; Pierre Yves Benhamou
Journal:  J Diabetes Sci Technol       Date:  2014-08-04

8.  Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

Authors:  Steven J Russell; Firas H El-Khatib; Manasi Sinha; Kendra L Magyar; Katherine McKeon; Laura G Goergen; Courtney Balliro; Mallory A Hillard; David M Nathan; Edward R Damiano
Journal:  N Engl J Med       Date:  2014-06-15       Impact factor: 91.245

9.  Multi-level Supervision and Modification of Artificial Pancreas Control System.

Authors:  Jianyuan Feng; Iman Hajizadeh; Xia Yu; Mudassir Rashid; Kamuran Turksoy; Sediqeh Samadi; Mert Sevil; Nicole Hobbs; Rachel Brandt; Caterina Lazaro; Zacharie Maloney; Elizabeth Littlejohn; Louis H Philipson; Ali Cinar
Journal:  Comput Chem Eng       Date:  2018-02-10       Impact factor: 3.845

10.  Enhanced Model Predictive Control (eMPC) Strategy for Automated Glucose Control.

Authors:  Joon Bok Lee; Eyal Dassau; Ravi Gondhalekar; Dale E Seborg; Jordan E Pinsker; Francis J Doyle
Journal:  Ind Eng Chem Res       Date:  2016-10-27       Impact factor: 3.720

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.